- Country: Turkey
- Summary: Automatic Nucleic Acid Isolation Device will be Acquired
- TRT Ref No: 58198918
- Deadline: 20 Oct 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 2021/609503
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Automatic Nucleic Acid Isolation Device will be acquired
nature, type and quantity: 1 automatic nucleic acid isolation device will be made. Detailed information can be reached from the administrative specification in the tender document in EKAP.
Delivery locations: Erzurum Veterinary Control Institute Directorate
Delivery Date: Erzurum Veterinary Control Institute Directorate will be delivered to the organization warehouse under the Technical Specification within the Technical Specification within 30 Calendar Days.
Date to work: Contract
tender date and time: 20.10.2021 - 1000 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAutomatic Nucleic Acid Isolation Device will be Acquired - Turkey Tender
The ERZURUM INVESTMENT MONITORING AND COORDINATION, a Government sector organization in Turkey, has announced a new tender for Automatic Nucleic Acid Isolation Device will be Acquired. This tender is published on TurkeyTenders under TRT Ref No: 58198918 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-10-20.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
